Lawrence Mendelsohn
Analyst · B. Riley FBR
Thank you, Operator. Thank you, everybody, for joining us on Ajax's third quarter investor call. I want to wish everybody a happy Election Day. And with that, on the second page of the presentation, I want have everybody take a quick look at the safe harbor disclosure and from there we can go on. As an introduction, we had a very successful value-building quarter. We bought a bunch of loans at good prices, we expanded our loan seller base, we added nearly $200 million of co-investments with institutional partners. We closed 2 securitizations in the last week of September with very good execution, both in advance rates on the senior bond structure as well as the cost of funds. And we continue to see rises in net interest income, even though average loans on our balance sheet in Q3 was lower than it was in Q2. Other than expected REO impairments, which I'll discuss a bit later in this call, the quarter was all positive. On Page 3, business overview, many of you have seen this page before but we've had a lot of things that have - these things have advanced. Our sourcing network continues to be an extremely important piece of our business. It's very important to our ability to acquire the types of loans that we want, in the locations that we want and the prices we pay relative to others, you'll see that in a couple of things as we discuss today, one, some loans that we sold but also in - what's going on in Q4 and brand that our sourcing network has created. We use our manager's proprietary analytics to price each pool, we analyze large amounts of data to determine target loan characteristics and to develop pattern and algorithms for both pricing loans and servicing loans. And you'll see in the numbers, just what that means in terms of what it does for our interest income and our yield increasing and the cash flow velocity that we're seeing on the loans that we're acquiring. Our servicer just as important, if you remember, our servicer, Gregory Funding, we own 8% of it, and we have warrants on another 12%. We think the servicer has significant value optionality, especially given the growth of our institutional co-investments and additional third-party institutions that have reach out to us about buying loans with us and through us. The other thing are analytics and the processes of our manager and servicer enable us to do is to broaden our reach through joint ventures with institutional partners and also it enables us to see loans from even larger sellers more frequently and in accustom and loan-by-loan pricing way rather than poor competitive bids. We use moderate non-mark to market leverage, average leverage in Q3 was actually lower than that in Q2 and lower than that in Q1 as well. So you'll see that ROE actually has increased in Q3 versus Q2, even though leverage was a little bit lower. Before we get into the actual numbers, I just want to kind of do a little walk-through of the different pieces. There's several important pieces to the per share numbers, the per share map in Q3, 2018, so like we did last quarter, I just want to walk you through the different pieces. First and the most important piece, we increased our interest income and net interest margin as our cash flow velocity continues. This increase loan yields and interest income despite a lower average loan balance during the quarter, on the flip side, you also see a small uptick in interest expense, resulting from accelerating the amortization of deferred issuance costs on our outstanding securitization debt as a result of the higher cash flow on the underlying loans. Higher cash flow velocity leads to faster pay down on the related debt, which leads to faster amortization of the related deferred issuance cost, as a result, you have a little bit uptick in cost. Second, we called our 2016-A and 2016-B securitizations in September - in the last week of September. We took a charge of $836,000 or approximately $0.045 a share, this amount would have been amortized in full during the 12-month period ending Q3, 2019, because there was one more year remaining in the amortization period. Like calling the bonds early, we accelerated the remaining amortizing amount to a onetime charge. We believe that the financing costs and advance rates from new securitization is more than make up for this in the securitizations, we did in the last week of September, one was an 80% advance rate at 3.75% at par, and one was an 82% advance rate at 4.30% at par. Third, our quarterly REO impairment was approximately $0.048 per share, as we've mentioned on previous quarterly calls, REO impairment happens first under GAAP and sales gains happen second. Our REO portfolio continues to have expected future gains on a net basis. Additionally, any foreclosure that results in a third-party property sale rather than becoming an REO is accounted for as a loan payoff in loan pool accounting for GAAP and does not offset any REO impairments. In Q3, we had 46 foreclosure outcomes, of which 27 ended up as third-party sales and 19 became REO. The profits of the 27 third-party sales became interest income and not REO gains and losses. Approximately, half of the REO impairment comes from 2 properties, 1 in Western Passaic County, New Jersey, and 1 in Royal, Colorado. The interiors of the property seem to have been purposely impacted during the resolution time line. Fourth, we took an impairment of $0.02 per share on the remaining $23 million of UPB from our $100 million 2014 NPL purchases. Based on the property conditions and expected time lines, we have reduced our yield expectation on the remainder of this $23 million by 0.4% or 40 basis points, which results in a onetime impairment of approximately $380,000 or approximately $0.02 per share. As our portfolio yield and interest income increases indicate, we're seeing the opposite effects in our later acquisitions. From a GAAP perspective, if we were to account on the mark-to-market basis similar to many other companies in the mortgage REIT space, the aforementioned impairments would be blended into our large built-in gain on our loan portfolio. However, we choose not to mark-to-market loans because unlike securities loans don't really have readily available dependable marks. As a result, we get to take charges for the negative impairments but we don't get to write up assets when they are worth more. Altogether, if you take these 4 pieces, it's approximately $0.11 a share, which would normalize the EPS to approximately $0.46. On the interest income side, one thing that's important to note in the second bullet point on the Highlights Page is that we only owned all the $65 million we purchased in Q3 for on average 9 days. So we really receive no interest income during the quarter from what we bought in Q3, but we did have all the related loan diligence expense to those loans in Q3. So we'll see the benefit of the $65 million in Q4 with the expense having been in Q3. The other thing, I want to mention is we sold some loans in Q3 right at the very end of the quarter into a joint venture, and we retained the 63% interest in that joint venture. For the 37% that we sold, we have a gain of $2.1 million on the sale, which implies if you - we're to sell 100% about $5.7 million, however, since we still own 63%, we can - we continue to consolidate the loans in our financials, and the gain as a result, will be amortized over the life of the loans, even though we did receive the sales proceeds and the cash representative of that gain. If we jump to Page 5. You can see our portfolio overview, we have about 3% of our portfolio is nonperforming loans and about 97% RPLs. RPLs continue to increase as a percentage, and you can see in Q3, the lion share of what we bought was RPL. REO is principally held for sale, it turns into cash over a relatively short period of time. We've seen a decline in REO value at the higher end in certain states, materially affected by the limits on deductibility under the new tax law. So if you were to split certain states or locations within states, Northern New Jersey, for example, parts of suburban New York City Metro and Connecticut, if you were to split those into the deciles, 1 through 10, with 1 being the lowest and 10 being the highest, we're clearly seeing the highest impact in deciles 8, 9 and 10 in those states, and in fact, the property in Western Passaic County, New Jersey would fit into that bucket that we took the impairment on. On Page 6, our reperforming loan portfolio. We continue to buy lower LTV loans with overall RPL purchase of 61.9% of property value and about 85% of unpaid principal balance. The price of property value does not include any home price appreciation since acquisition. Basically the strategy is continuing to play offense and defense at the same time, and we're able to do that because of our private negotiated sales with sellers. So we're able to pick the loans we want in many of the acquisition cases in each quarter. And one of the things we concentrated specifically is our location concentration and the deciles at the underlying property values that we're looking for as a protection against any future declines that may happen in home prices. On page 7, our nonperforming loans. Nonperforming loans have been declining in absolute dollars for us. In Q3, 2018, we created 19 REO's foreclosure, but sold 32. REO impairments continue to be primarily driven by borrower-induced property damage and to a much lesser extent home price declines in certain specific locations. For our NPL portfolio, the purchase price to property value is approximately 53.7%, as you might imagine higher LTV NPLs become REO sooner, and create impairment sooner and lower LTV NPLs are more likely to become performing loans or to pay off in full. On Page 8, you can see our map, we have not changed our targeted markets between Q2 and Q3, California continues to represent the largest segment of our portfolio, particularly, Los Angeles, Orange and Sand Diego counties, we're seeing consistent performance patterns in these markets, particularly California, urban centers. We expect the California percentage of our portfolio to increase from our Q4 2018 pending acquisitions. On Page 9, this is very important in terms of its reflection on NAV and why we think we have a very significant kind of built-in value gain in our loan portfolio. Approximately, $1.05 billion of our portfolio is 12 consecutive payments or better, up approximately $400 million from year-end 2017. Approximately, $1.2 billion is seventh consecutive payments or better. For the loans that we buy, and the way our servicer manages these loans, our analytic data suggest that once a loan becomes 7 for 7, there's a 91% to 93% probability that it becomes 12 of 12. Once loans are 12 of 12, an NBA current for that period, they're worth very close to par if not above par depending on their coupon and LTV, and we see a significant numbers of AAA-rated transactions getting done with these clean pay loans. In addition to increasing cash flow and net asset value, the significant outperformance of our loans also lowers our asset-based cost of funds over time. We've seen from our last 7 securitizations including 2 in September of 2018, that our loan cash flow velocity enables us to push advance rates up and lower cost of funds. While our total average asset base debt cost increased in Q3, it was driven by prepayments in cash flow velocity causing more rapid amortization for issuance cost rather than rate. Page 10, what happens since September 30, and the answer is a lot. It's been a very busy fourth quarter already. We've already closed $103 million of purchases post September 30, $28.3 million of which was acquired to a nonconsolidated joint venture with third-party institutional investors. And then we have approximately $670 million of loans under contract, much of which is in joint ventures with third-party institutional investors. We also have another $3.5 million of small balance commercial loans under contract, and we have 3 properties - 3 small apartment buildings in urban Miami, Houston and Raleigh, North Carolina. We have already 14 total transactions either closed or in process, we're also currently looking at 5 or 6 more of that sellers have reached out to us and asked if we could get done by year-end for them. So we're evaluating those loan portfolios currently. One consistent pattern, however, if you look at the numbers of everything under contract is the low price to collateral value. On the RPLs, 55% of collateral; on the NPLs, 57% of collateral; on the SBC, 65% of collateral. And the overwhelming majority of these underlying properties are what we call deciles 4 through 7 in each location. The other thing I would say is approximately $250 million of the $560 million RPLs are in the state of California. If we jump to Page 11, some financial metrics. One of the things every joint ventures of institutional investors does is to the extent we own more than 20%, we have to consolidate the loans under balance sheet, which skews some of the numbers proportionally. So we - here, we have excluded the consolidation of our 2017-D and 2018-C, where we don't own a 100%. And we effectively, the first column, deconsolidated it. One of the things to see is the continuing materially increasing cash flow velocity on loans is good for yield in NAV creation, the yield of 8.9% includes the reduced yield taken on the 2014 NPLs, so you can see that our yield increases have been pretty steady and cash flow velocity is the real driving force on that. If we could drop-down a little bit, if you take out the impairment - the REO impairments, our ROE was actually 12.1%, return on average equity was actually 12.1% during the quarter, up from Q2 and up from Q1. Even though average leverage in Q3 was actually a little bit lower than it was in Q2 and Q1. And then, if we look at the ending leverage ratio at the bottom of the page, you'll see that average leverage during the quarter was less than ending leverage, that's because we closed 2 securitizations with significant advance rates right at the very end of the quarter. And as a result, ending leverage is a little bit higher than it was throughout the quarter, and we would expect to see that in Q4 as well. After that, we have the income statement and balance sheet, and I'm happy to take any questions that anybody might have.